Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SwitchPoint Ventures is a Nashville-based AI venture studio that partners with companies to design, validate, commercialize, and scale custom artificial intelligence products. The firm is not a drug developer; instead, it builds and co-creates software and data-driven businesses across industries, including healthcare. In healthcare, it has helped launch products such as Polaris AI for clinician demand forecasting and scheduling, Winnow for clinician recruitment analytics, and Scout Insight for decision support in healthcare real estate and expansion strategy. The company operates through joint ventures, revenue shares, and equity participation with partners rather than through a traditional biopharma pipeline model. Its business is best characterized as commercial-stage AI product creation and innovation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SwitchPoint Ventures.